Physician profile
John P Neis
NPI 1851616148
$2,140.36
in general payments reported to CMS, 2019-2025
11 companies · $284 in 2025
The $284 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.01 · 2020: $108 · 2021: $249 · 2023: $1,106 · 2024: $376 · 2025: $284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,142 · Travel and Lodging: $567 · Education: $56.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,142.09 |
| Travel and Lodging | $567.31 |
| Education | $56.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,361.65 | 2023-2025 | Inspire |
| Aerin Medical INC. | $242.65 | 2021-2024 | |
| Medtronic, INC. | $154.08 | 2023-2024 | Propel, Stealthstation S8 Platform |
| Regeneron Healthcare Solutions, INC. | $109.75 | 2023-2025 | Dupixent |
| Karl Storz Endoscopy-America | $107.63 | 2020 | |
| Novartis Pharmaceuticals Corporation | $58.02 | 2025 | |
| Glaxosmithkline, LLC. | $36.39 | 2021-2025 | Nucala |
| Genzyme Corporation | $20.95 | 2025 | |
| Optinose US, INC. | $20.01 | 2024 | |
| Stryker Corporation | $18.01 | 2019 | |
| Cook Medical LLC | $11.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Neis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.